Saturday, January 19, 2008

However, all the drugs had pros and cons.

Though Avandia was linked to greater unit of measurement gain, higher LDL levels, and more inflation, it also came with version benefits.
Patients taking Avandia were less likely to have gastrointestinal problems than those taking metformin.
They were less likely to have rake kale that was too low than patients taking glyburide.
Avandia is the newest and most expensive of the tercet drugs.
“The potential risks and benefits, the conspicuousness of adverse events, and the costs of these tercet drugs should all be considered” in choosing diabetes drugs, conclude the researchers.
The examination was funded by Avandia’s business concern, GlaxoSmithKline.
This is a part of article However, all the drugs had pros and cons. Taken from "Buy Avandia Rosiglitazone" Information Blog

No comments: